254. Porphyria Clinical trials / Disease details
Clinical trials : 72 / Drugs : 53 - (DrugBank : 16) / Drug target genes : 19 - Drug target pathways : 35
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01422915 (ClinicalTrials.gov) | May 2011 | 23/8/2011 | Sorbent Therapy of the Cutaneous Porphyrias | Sorbent Therapy of the Cutaneous Porphyrias | Erythropoietic Protoporphyria | Drug: Colestipol | Brigham and Women's Hospital | NULL | Completed | 22 Years | 60 Years | All | 4 | Phase 2/Phase 3 | United States |